Page last updated: 2024-11-05

thalidomide and Pseudarthrosis

thalidomide has been researched along with Pseudarthrosis in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Pseudarthrosis: A pathologic entity characterized by deossification of a weight-bearing long bone, followed by bending and pathologic fracture, with inability to form normal BONY CALLUS leading to existence of the false joint that gives the condition its name. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fixsen, JA1
Lloyd-Roberts, GC1

Other Studies

1 other study available for thalidomide and Pseudarthrosis

ArticleYear
The natural history and early treatment of proximal femoral dysplasia.
    The Journal of bone and joint surgery. British volume, 1974, Volume: 56, Issue:1

    Topics: Acetabulum; Arthrodesis; Bone Diseases, Developmental; Femur; Femur Head; Fibula; Humans; Ilium; Inf

1974